Altered synovial fibroblast (SF) transcriptional activity is a key factor in the disease progression of rheumatoid arthritis (RA). To determine the transcriptional regulatory network associated with SF response to an RA proinflammatory stimulus we applied a CARRIE reverse engineering approach to microarray gene expression data from SFs treated with RA synovial fluid. The association of the inferred gene network with RA susceptibility was further analyzed by a case-control study of promoter single-nucleotide polymorphisms, and the presence of epistatic interactions was determined using the multifactor dimensionality reduction methodology. Our findings suggest that a specific NF-κB transcriptional regulatory network of 13 genes is associated with SF response to RA proinflammatory stimulus and identify a significant epistatic association of two of its genes, IL6 and IL4I1, with RA susceptibility.
Rheumatoid arthritis (RA) is a chronic inflammatory disease with a prevalence of approximately 1% that primarily affects diarthrodial joints, in which synovial inflammation leads to cartilage and bone destruction. The synovial membrane, a rather acellular tissue in normal conditions, becomes hypertrophic and is composed mainly of synovial fibroblasts (SFs) [1] . SFs in RA display an activated phenotype, which significantly contributes to disease initiation and progression [2, 3] . Although several transcription factors like AP-1 [4] , NF-κB [5] , or p53 [6] have been previously associated with SF altered activity, no precise transcriptional regulatory network has been associated with RA pathophysiology. With the advent of microarray technology, global gene expression data can now be used to model transcriptional networks associated with molecular disease mechanisms.
Modeling transcriptional regulatory networks is considered a reverse engineering problem. By reverse engineering we understand the process of determining the structure of a system by reasoning backward from observations of its behavior [7] . Different methods have been recently described to determine functional networks from microarray gene expression data. After providing success with lower eukaryotes [8] they are also proving successful in defining regulatory networks in the first studies with human gene expression data [9] .
Microarray analysis of cultured SFs treated with a single factor can be useful to study molecular mechanisms relevant to RA [10, 11] . However, the synovial environment in RA is extremely complex, with the interplay of cytokines, chemokines, matrix-degrading enzymes, growth factors, and immune cell particles [12] . Furthermore, several RA proinflammatory factors like TNF and IL1β can regulate gene transcription via convergent signaling pathways. Synovial fluid is known to contain most of the proinflammatory factors associated with RA pathophysiology. Thus we hypothesize that SF in vitro treatment with a complex proinflammatory stimulus like RA synovial fluid can help to identify the specific SF transcriptional network associated with this disease.
Transcriptional regulatory networks are theoretically prone to the presence of epistatic effects [13] . Epistasis, or more specifically, genetic epistasis, can be defined as the nonindependent effect of genetic polymorphisms over a particular trait in an individual [14] . Until now, the analysis of epistatic effects on human diseases has been limited by the exponential number of combinations to be analyzed in multilocus models. Recently, however, data mining approaches for dimensionality reduction in the analysis of gene × gene and gene × environment interactions have proven useful in the detection and characterization of epistatic effects in human diseases [13, 15] .
The present study was therefore designed to determine, first, whether a particular transcriptional regulatory network is involved in SF response to RA synovial fluid stimulation and, second, whether promoter polymorphisms in the genes of this network are associated with susceptibility to RA via epistatic interactions. To answer these questions we studied the differential gene expression profiles from cultured synovial fibroblasts with and without RA synovial fluid stimulation. We applied CARRIE, a new method of transcriptional network ascertainment that couples gene expression analysis with promoter sequence information to infer regulatory relationships [16] , to the results. After defining the associated transcriptional network, we analyzed the presence of epistatic interactions associated with RA susceptibility between promoter singlenucleotide polymorphisms (SNPs) from the coregulated genes by using the multifactor dimensionality reduction (MDR) method [17] .
Results

Differentially expressed genes and significant Gene Ontology (GO) terms
Using conservative criteria for differential expression we obtained a total of 157 genes differentially expressed between treatment groups (Supplementary Table S1 ). A partial list (fold change > 3) of differentially expressed genes is shown in Table 1 .
To evaluate the global gene expression changes on SF in response to an RA synovial fluid stimulus we compared GO terms from differentially expressed genes. Statistically overrepresented GO terms (p < 0.05) were immune response (GO: 0006955), response to biotic stimulus (GO: 0009607), defense response (GO: 0006952), receptor binding (GO: 0005102), cytokine activity (GO: 0005125), and response to wounding (GO: 0009611). The complete list of genes associated with each differentially expressed GO can be found in Supplementary  Table S2 .
Analysis of transcriptional regulatory networks
Determination of significant transcription factor matrices
We determined those transcription factors that most likely control the response of SFs to RA synovial fluid using CARRIE. We found that, from all significant matrices (Fig. 1) , the NF-κB distribution matrix stands out as the most clearly associated. NF-κB has a p value four orders of magnitude more significant than the immediate associated transcription factor (TF).
Determination of NF-κB regulatory network
We inferred the transcriptional regulatory network of NF-κB involved in the SF response to RA synovial fluid using CARRIE (Fig. 2) . Although no significant expression change was observed for NF-κB itself, a significant relationship with 13 coregulated genes was assessed. Of these, 11 were up-regulated by NF-κB action, whereas 2 were down-regulated.
Population-based association analysis of NF-κB-coregulated genes
To evaluate the association of the regulatory regions of the 13 genes included in the NF-κB network we genotyped SNPs from or near to the proximal promoter. We finally analyzed a total of 22 SNPs, listed in Table 2 . We found all polymorphisms to be in Hardy-Weinberg equilibrium (p > 0.001, data not shown). From all polymorphisms tested rs1290754 (IL4I1), rs2633958 (COL7A1), rs4694636 (IL8), and rs344589 (CD70) were associated at p < 0.05 although significance was not maintained after Bonferroni correction. We found strong pairwise linkage disequilibrium (LD) between markers from the same genetic region (D′ > 0.98), except for CD70 (D′ = 0.78). None of the estimated multimarker haplotypes was significantly associated with RA (Table 2) .
Genetic epistasis analysis of NF-κB-coregulated genes
We analyzed the presence of epistatic interactions evaluating all possible two-to seven-way SNP combinations. From these, the two-SNP combination of rs1290754 (IL4I1) with rs1800797 (IL6) was the best model for RA risk prediction (Fig. 3, left) . The testing accuracy of the selected model was 0.599 (p < 0.02 based on a 100-fold permutation test). The odds ratio for this model was 2.23 (95% CI 1.51, 3.28). Notably, when these two SNPs were merged as a single variable and the data reanalyzed it clearly came out as the best model, with a testing accuracy of 0.6 and a cross-validation count of 10 of 10 ( Fig. 3, right) . The entropy analysis [18] of the interaction between SNPs (Fig. 4) clearly shows the strong synergistic interaction between these two SNPs.
Discussion
This study shows that a particular transcriptional regulatory network is involved in SF response to RA synovial fluid stimulation. We found that from all transcriptional networks analyzed, the NF-κB regulatory network is markedly significant. In contrast, other known networks, like AP-1 or p-53, seem to have a secondary role in the response to this complex proinflammatory stimulus.
This study also shows that polymorphisms in genes of this transcriptional network are associated with susceptibility to RA via epistatic interactions. We found that high-order interactions between SNPs from IL4I1 (rs1290754) and IL6 (rs1800797) are significantly associated with risk to develop RA.
NF-κB transcriptional network
NF-κB is one of the TFs most strongly associated with RA pathogenesis, regulating the activities of many different genes in many cell types [19, 20] . We determined a highly statistical overrepresentation of NF-κB binding sites in the promoter regions of the coregulated genes (p < 1 × 10 −9 , Fig. 1 ). In this model, NF-κB is not differentially expressed, which is in Fig. 2 . Inferred transcriptional regulatory network mediating SF response to RA proinflammatory stimulus. Solid arrows between NF-κB (i.e., in red, not differentially expressed) and its target genes represent direct regulation predicted by ROVER. The "+" symbols represent stimulatory relationships and the "−" symbols denote inhibitory relationships. accordance with the fact that its activation takes place mainly at the posttranscriptional level through IκB phosphorylation and degradation [21] . Strikingly, however, we found a clear cutoff between NF-κB and the rest of the TFs (i.e., four orders of magnitude with the second most associated TF). Since synovial fluid is a complex mixture of various stimulating proinflammatory factors we would rather expect a less pronounced main TF prediction. It is even more striking if we compare the similarity between this result and the results obtained using the same inference methodology in yeast perturbation experiments [16] . In these studies different single-factor stimulation experiments, from which the main TF was already known, were used to validate CARRIE methodology.
In the present study we determined a specific transcriptional regulatory network of 13 genes for which there is evidence supporting their roles in SF NF-κB-mediated response in RA. CXC motif chemokines-CXCL1, CXCL2, CXCL3, and IL8-are regulated by NF-κB [22, 23] , are overexpressed by TNF and IL1β stimulation [24] , and have been demonstrated to be overexpressed in RA fibroblasts [22] . Similarly CSF3, IL1F9, CD70, and COL7A1 can be activated in RA fibroblasts or other cell types after TNF and IL1β stimulation [24] [25] [26] [27] or in RA animal models [28] . IL6, one of the crucial proinflammatory cytokines in RA and which is clearly associated with RA fibroblast altered expression, has a demonstrated NF-κB-induced upregulation [29] , together with IL4I1 [30] , TRIB3 [31] , and SAA1 [32] . The latter, however is significantly down-regulated in our study, an effect for which we have no explanation. Finally, FAM5B (i.e., BMP/retinoic acid-inducible neural-specific protein) is a recently characterized gene with a perforin-like conserved domain structure [33] and, to our knowledge, this study is the first evidence for NF-κB transcriptional control.
IL4I1 × IL6 epistatic model for RA risk
Several lines of evidence point to the relevance of epistatic effects in RA etiology. The most compelling data come from quantitative trait analysis on mouse [34] and rat [35, 36] RA models. Although epidemiological modeling studies of the disease have provided the theoretical framework for epistasis in RA [37] , very few studies have analyzed the presence of such interactions in humans [38, 39] . One of the reasons for the lack of these studies is the statistical and computational challenge that is associated with the analysis of genetic polymorphism combinations and disease susceptibility [18] . The multifactor dimensionality reduction approach used in this study attempts to address this limitation and is able to determine the multilocus combinations associated with high risk to develop disease [13] .
Analysis of main effects in the IL4I1 promoter SNPs showed a modest association at the genotypic level for rs1290754 (p < 0.05, Table 2 ) although not significant after Bonferroni correction (data not shown). To our knowledge, this is the first study to analyze the association between IL4I1 gene polymorphisms with RA. On the other hand, IL6 polymorphisms association with RA have already been studied in the Spanish population [40] and, in agreement with this previous study, we did not detect a significant main effect after allelic and genotypic analysis (Table 2) . However, by analyzing the highorder interactions between all candidate polymorphisms and RA using MDR we identified a significant interaction between IL6 promoter SNP rs1800797 and IL4I1 promoter SNP rs1290754 (OR 2.2; 95% CI 1.5109, 3.2806; p < 0.02). Even after merging both SNPs as a unique variable, it is still the model (i.e., single variable model in this case) with the highest testing accuracy (Fig. 3) .
How does this epistatic effect increase the susceptibility to develop RA? While IL6 is a well-known proinflammatory cytokine clearly associated with RA pathology, the role of IL4I1 in RA still needs to be explored. One intriguing evidence that could support the active role of this protein in RA pathophysiology could be its identification as an autosomal H locus [41] . H loci are minor histocompatibility antigens that are processed by MHC class I and class II molecules and that can be responsible for allograft rejection in transplant therapies. Studies in mice found that the H46 locus, containing Il4i1 (i.e., the murine homologue of IL4I1), synthesizes a peptide that is presented by MHC class II that has the potential to elicit CD4 + T cell responses in autoimmunity. Autoantigen activation of T cells is one of the main models for the etiology and pathogenesis of RA [12] . The interaction dendrogram method implemented in MDR software (Fig. 4) allowed us to determine the nature of the interaction as a high-degree synergy between IL6 and IL4I1 promoter polymorphisms. Thus, it is tempting to speculate that high-risk combinations in this two genes could led to the proactive role of the synovial fibroblast in the development of RA.
Limitations of the approach
In our view, the scope of the study could be limited mainly in two ways. First, is the stimulation of synovial fibroblasts with RA synovial fluid a valid model to study RA pathophysiology? Second, is CARRIE a valid reverse engineering approach to characterize relevant transcriptional regulatory networks in human disease?
RA synovial fluid is formed by the secretions of multiple activated immune and nonimmune cells, which give rise to a complex proinflammatory environment that contributes to the progression of disease. Thus, the transcriptional profiling of SF stimulated with RA synovial fluid should yield more valuable Fig. 4 . Dendrogram of interactions between NF-κB transcription regulatory network polymorphisms. The colors used depict the degree of synergy, ranging from red (highest information gain) to blue (highest information redundancy). Note that for the interaction between IL4I1 (rs1290754) and IL6 (rs1800797) promoter SNPs, the degree of synergy (gain of information) between them is highest.
insights into disease molecular mechanisms than single cytokine stimulation. Accordingly, several significantly differentially expressed genes we have detected, like INHBA [42] , IL11 [43] , PTGS2 [44] , IL6 [22] , or IL23A [45] , have been previously associated with RA synovial pathophysiology (Table  1 and Supplementary Table S1 ). Furthermore, by using this experimental model we have been able to identify a two-loci epistatic interaction that is significantly associated with susceptibility to developing RA.
Reverse engineering is a new kind of analytical approach that has been only recently used with human data [9] . For this study we have made the assumption that the inference method implemented in CARRIE can efficiently model the transcriptional regulatory network associated with SF response to an RA synovial fluid stimulus. One of the limitations of this methodology is that it is subject to the completeness of the TRANS-FAC human database. Therefore, statistical error could have been introduced by absent position-specific scoring matrices (PSSMs) or weak promoter binding sites. However, the highly significant statistical association of the NF-κB transcriptional regulatory network and the previous implication of several of its genes in RA pathophysiology give strong support to the effectiveness of this methodology. To our knowledge, this is the first study to apply CARRIE methodology on human data.
Conclusion
In summary, this study shows that a specific NF-κB transcriptional regulatory network is significantly associated with synovial fibroblast response to RA synovial fluid and that an epistatic interaction between two of its genes, IL6 and IL4I1, is significantly associated with the risk of developing RA. Although other relevant SF regulatory networks cannot be excluded in RA pathophysiology, it is the first demonstration of a transcriptional regulatory network associated with this disease. We believe that the definition of relevant transcriptional networks by reverse engineering can greatly accelerate the search for disease susceptibility genes.
Materials and methods
Cell culture and synovial fluid
Osteoarthritis (OA) SFs have been widely used as a reference for the experimental study of synovial membrane. In this study, synovial membrane was obtained from an OA patient undergoing knee joint replacement surgery. The membrane was thoroughly minced to ∼1 mm 3 and incubated for 2 h at 37°C with 1 mg/ml collagenase I A (Sigma, Spain) under continuous agitation. Cells were pelleted and cultured in DMEM with L-glutamine (Gibco Life Technologies, Spain) with 10% FCS and penicillin-streptomycin (50 IU/ml) (Gibco Life Technologies, Spain) at 37°C with 5% CO 2 in a humidified atmosphere.
Synovial fluid was obtained from an inflamed knee joint of a 55-year-old RA female patient in a sterile nonheparinized tube. From the time of extraction to centrifugation (1500g, 10 min) the sample was continuously kept at 4°C. The acellular supernatant was kept at −20°C until cell treatment.
Synovial fibroblast stimulation and microarray analysis
After the third passage, the synovial cell culture was divided into control and treatment groups. Control cells were cultured with fresh medium (DMEM) without FCS, whereas treated cells were cultured in a fivefold diluted synovial fluid (80% DMEM). After 12 h of treatment, total RNA was extracted from both cell groups using a column affinity purification method (RNeasy; Qiagen, Spain). For each class three RNA samples were obtained and analyzed separately in Human IA CodeLink Expression Bioarrays (General Electric Healthcare, Spain) representing ∼20K UniGene entries. Briefly, each RNA was in vitro amplified, hybridized, stained, and scanned using the manufacturer's instructions. Signal and background intensities were also extracted using the manufacturer's recommended software (CodeLink version 2.3.2) . Normalization of background-corrected intensities was performed stepwise: intraclass replicates were normalized using cyclic lowess normalization and both classes were finally normalized using quantile normalization. Data transformation and normalization were carried out using the libraries provided as part of the R statistical language package version 2.1.0 (http://cran.r-project.org). Primary data and supplementary tables can also be accessed at http://www.urr.cat.
Differential gene expression and gene ontologies
Differentially expressed genes in fibroblasts stimulated with RA synovial fluid compared to controls were identified using the two-sample Welch t statistic implemented in Bioconductor's "multtest" package (http://www.bioconductor. org). To correct for multiple testing, a modified Bonferroni correction procedure was used. Since for each class we have analyzed RNA samples belonging to the same biological source (i.e., same individual) we decided to use a more stringent statistical cutoff as a measure of differential expression (i.e., ≥2-fold change in mRNA abundance, adjusted p value <0.00001).
Functional analysis of differentially expressed genes was performed using the program GOstat (http://gostat.wehi.edu.au/). Briefly, significantly overexpressed genes were selected as a test group and underexpressed genes were selected as the reference group. GO terms from both groups are then compared via Fisher's exact test and approximated p values are computed for each of them. Since the number of GO terms tested is large, we corrected the nominal p values using the Bonferroni correction procedure.
Reverse engineering of the transcriptional regulatory network associated with SF response to synovial fluid using CARRIE Normalized data and differential expression significance p values were uploaded into the CARRIE server (http://zlab.bu.edu/CarrieServer/html/). CARRIE is a computational method for transcriptional regulatory network inference from microarray analysis using promoter sequence information [16] . Briefly, microarray results are used to discriminate positive (altered expression) from negative (expressed but constant) groups of genes. From these two groups, statistically overrepresented TFs whose binding sites are more abundant in the positive set relative to the negative set are determined using the ROVER algorithm. Moreover, ROVER also identifies overabundant promoters that are likely to be regulated by the predicted TFs. All the information is finally gathered into CARRIE, where a graphical network is computed highlighting regulatory relationships between TFs with regulated genes.
We used the same criteria for significant expression change as for differential expression analysis (i.e., adjusted p < 0.00001, fold change ≥2). PSSMs for human TF binding sites were obtained from the TRANSFAC Professional version 7.2 database. Promoter sequences for the list genes in CodeLink Human IA Bioarrays were downloaded using the PromoSer server (http://biowulf.bu. edu/zlab/PromoSer/) version 3.0 (based on NCBI Build 34). For each gene 2000 bases upstream of the transcription start site (TSS) and 50 bases downstream of the TSS were retrieved, selecting only the sequence that was closest upstream to the 5′ end, excluding guessed entries and ignoring promoter region overlaps or assembly gaps. The frequency of significant binding sites for a single TF in a random promoter was set to 0.0001 and the cutoff for binding site overabundance was p = 0.001.
Since the TRANSFAC collection of matrices contains, in some cases, many matrices for a particular TF, we applied redundancy reduction to obtain only the highest scoring PSSM for each group. Significance values were also corrected for multiple testing using the default Benjamini and Yekutieli stepped correction for control of the FDR.
Gene association study: population selection
To increase the power of the sample-based case-control design we used the hypernormal control group strategy described by Morton and Collins [46] . Hypernormal controls are defined as those individuals with the lowest liability to develop the disease. By using extreme discordant phenotypes the efficiency of the association study is usually much greater than with normal controls. The details of the hypernormal control group (n = 181) and the cohort of RA patients (n = 257) are given in Ref. [47] . This study was approved by the ethics committee of the Institut de Recerca Hospital Universitari Vall d'Hebron.
Gene association study: SNP selection and genotyping
For all 13 genes coregulated in NF-κB transcriptional network we selected SNPs in or close to their proximal promoter (2000 bases upstream from TSS). We used Entrez dbSNP (Human Build 35.1) and HapMap (HapMap Public Release 18) database information to select the most informative SNPs. We used the following selection criteria: (i) heterozygosity > 0.2 in Caucasian European samples and (ii) in the proximal promoter or in the LD block that encompasses this region, built under standard definition [48] . In those cases in which the second criterion did not apply we favored the selection of multiple close SNPs to increase the informativeness of the locus by building multimarker haplotypes.
Genotyping was done on a MALDI-TOF mass spectrometer (MassArray System) using the Spectrodesigner software (Sequenom) for primer selection and multiplexing and the homogeneous mass-extension process for producing primer extension products. We regenotyped >30% of the samples in cases and controls with a genotype concordance of 100% between independent runs. Genotyping was done at the CEGEN, Nodo de Santiago, Santiago de Compostela, Spain. All primer sequences are available on request.
Population-based association analysis
All association analyses were performed using R (version 2.1.0). HardyWeinberg equilibrium was tested using the Genetics package. Association analysis of each SNP was performed using Pearson χ 2 test of the null hypothesis, and exact p values were obtained by Monte Carlo simulation (2000 replicates).
Haplotype analysis was performed using the Genecounting/Permute program implemented in the Gap package. Briefly, case-control haplotypes are analyzed using model-free analysis and permutation tests of allelic association [49] .
Genetic epistasis analysis using multifactor dimensionality reduction
We analyzed high-order interactions between NF-κB transcriptional regulatory network SNPs using the MDR method. MDR is a nonparametric model-free method designed to analyze gene × gene or gene × environment interactions [13] . Traditionally, the analysis of such high-dimensional data has been hampered by the limitations of statistical modeling techniques. MDR attempts to address this limitation using a data reduction approach called constructive induction [18] . Basically, multilocus genotypes (n dimensions) are pooled into a single risk predictor variable with only two dimensions (i.e., high risk or low risk). The predictive performance of the best model is then assessed through k-fold cross-validation and its significance determined through Monte Carlo permutation testing. It is important to note that MDR assigns a data point as "unknown" when there are no data points for that genotype combination in the training set. This becomes of particular relevance for larger n-way combination analyses, since more contingency-table cells can contain no observations. The present analysis was performed with the MDR software Beta 1.0.0 RC1 (http://www.epistasis.org/open-source-mdr-project.html). Statistical interpretation of the significance of the MDR model is facilitated by the visualization of an interaction dendrogram. This dendrogram is built from a hierarchical cluster analysis of entropy-based measures of interaction information between polymorphisms.
